Plasma and skin concentration of 5-methoxypsoralen in psoriatic patients after oral administration.

Zucchi, A; Raho, E; Marconi, B; Nicoli, S; Santini, M; Allegra, F; Colombo, P; Bettini, R; Santi, P

Zucchi, A; Raho, E; Marconi, B; Nicoli, S; Santini, M; Allegra, F; Colombo, P; Bettini, R; Santi, P.

Affiliation

Zucchi A; Institute of Dermatology, Faculty of Medicine, University of Parma, Parma, Italy.

J Invest Dermatol ; 117(2): 379-82, 2001 Aug.

Article in En | MEDLINE | ID: mdl-11511320

Subject(s)

Methoxsalen/administration & dosage; Methoxsalen/pharmacokinetics; PUVA Therapy; Psoriasis/drug therapy; 5-Methoxypsoralen; Administration, Oral; Adult; Dermis/chemistry; Epidermis/chemistry; Female; Humans; Male; Methoxsalen/analogs & derivatives; Methoxsalen/blood; Middle Aged; Tissue Distribution

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / PUVA Therapy / Methoxsalen Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Invest Dermatol Year: 2001 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links